IQVIA on Thursday announced the launch of its new Virtual Research Solutions (VRS), a brand-new suite of “study options offering advances in patient-centric trial design and execution,” according to a press release.
The press release states the new suite combines high-grade information assets with “advanced analytics, technologies and critical domain expertise” to develop patient-centric trials and late-phase studies.
“IQVIA’s advances in technologies and analytics, combined with our expanding understanding of how the human experience informs human health, all point to an opportunity to rethink research in healthcare,” IQVIA Research and Development Solutions President Richard Staub said in a statement. “For instance, significant distances between patients and investigators, heavy time commitments for research participants, low patient enrollment and high dropout rates are challenges researchers regularly face.”
Staub says VRS can ease the impact of trials on a patients’ life while bolstering both patient and customer experience, as well as participant diversity.
To read the full press release, click here.